Research Explores Use of Benralizumab for Chronic Obstructive Pulmonary Disease

by Kathy Jones on  September 8, 2014 at 8:29 PM Research News
RSS Email Print This Page Comment
Font : A-A+

Previous research has shown that chronic obstructive pulmonary disease (COPD) is associated with eosinophilic airway inflammation in 10-20% of patients.
 Research Explores Use of Benralizumab for Chronic Obstructive Pulmonary Disease
Research Explores Use of Benralizumab for Chronic Obstructive Pulmonary Disease

Benralizumab, a monoclonal antibody, has been shown to decrease the number of blood and sputum eosinophils. In this trial of 101 patients with COPD whether benralizumab reduces the number of acute exacerbations was investigated. Benralizumab was found to be no more effective at preventing acute COPD exacerbations than placebo overall. However, the authors conclude that subgroup analyses suggest more research into the use of benralizumab in patients with COPD and eosinophilia is required.



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Silicosis Modified Atkins Diet: All You Need to Know 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive